News

Unilife Medical Solutions (Unilife) has commenced final preparations for the commercial release and sale of its Unitract 1ml syringes, following the completion of device ageing studies for product

Borealis, a provider of chemical and plastics solutions, has announced its decision to withdraw all activities for the rotomoulding sector by March 31, 2010. Borealis has been committed

Durata Therapeutics (Durata) has acquired Vicuron Pharmaceuticals (Vicuron) from Pfizer (PFE). Durata is a newly formed biopharmaceutical company that was created to pursue late-stage clinical development of novel

Biovator and BASF have signed a collaboration agreement for final development of in-vitro test systems, capable of identifying the potential of chemical compounds to induce allergic reaction in

Seattle Genetics has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12m for rights to utilize Seattle Genetics’ antibody-drug

XenoTech has introduced its new product in the field of cryopreserved pooled human hepatocytes, CryostaX. The company said that CryostaX is the largest single-freeze pool of cryopreserved human

Neuralstem has reported that its Phase I trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) with its spinal cord stem cells has been approved by

Schott announced at the Pharma Symposium in Mainz, Germany that it has started mass production of its TopLyo pharmaceutical packaging for lyophilized (freezedried) drugs at its Muellheim, Germany

Mesa Laboratories has acquired the bottle cap torque testing business of Vibrac, a new Hampshire based company. Under this transaction, Vibrac is expected to sell the assets associated